In addition, the inhibition of autophagy drastically reduced the proliferation of MHC-II-restricted CD4+ T cells, suggesting that the delivery of tumor antigens to the autophagy pathway could become a novel strategy to enhance the antitumoral CD4+ T cell response. The gene discussed is CD4; the disease is neoplasm.